Clinic
Ochsner Lsu Health Shreveport - ST. Mary Medical Center, LLC
Ochsner Lsu Health Shreveport - ST. Mary Medical Center, LLC was paid $15.02M by Medicaid between May 2020 and Dec 2024, across 206 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 12% of everything it billed.
33Billing provider infoOCHSNER LSU HEALTH SHREVEPORT - ST. MARY MEDICAL CENTER, LLC
SHREVEPORT, LA 71101
SHREVEPORT, LA 71101
33aNPI1285253252assigned 04/10/2020
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$15.02M
24GClaims416,092
24DCodes billed206
24AFirst – last monthMay 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Louisiana
Rank by total paid#2 of 58
Median peer was paid$142K
This provider vs. median105×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,031 | $130K | |
| 2021 | 25,712 | $957K | |
| 2022 | 115,077 | $4.03M | |
| 2023 | 131,909 | $5.52M | |
| 2024incomplete | 141,363 | $4.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 62,888 | 46,470 | $1.80M |
| 76819 | Fetal biophysical profile; without non-stress testing | 8.1% | 22,395 | 9,989 | $1.22M |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 8.0% | 12,199 | 10,081 | $1.21M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.7% | 25,570 | 21,872 | $1.15M |
| 59025 | Fetal non-stress test | 5.1% | 9,195 | 6,596 | $762K |
| G0378 | Hospital observation service, per hour | 5.1% | 3,169 | 1,394 | $761K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 4.8% | 3,023 | 2,495 | $718K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.1% | 10,274 | 9,181 | $466K |
| 93325 | 3.1% | 4,855 | 4,001 | $465K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2.8% | 4,319 | 3,050 | $420K |
| G0379 | Direct admission of patient for hospital observation care | 2.3% | 1,377 | 1,098 | $349K |
| 93320 | 2.1% | 3,044 | 2,495 | $317K |
194 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.9% | 10,912 | $287K |
| 20610 | 1.9% | 2,228 | $285K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.9% | 10,930 | $284K |
| 64493 | 1.8% | 696 | $265K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 9,791 | $246K |
| 62323 | 1.5% | 952 | $232K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.5% | 398 | $222K |
| 20611 | 1.5% | 1,053 | $220K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 1.4% | 296 | $213K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 7,073 | $174K |
| 76820 | <1% | 4,157 | $141K | |
| 76825 | <1% | 632 | $120K | |
| 93304 | <1% | 647 | $111K | |
| 76801 | <1% | 1,432 | $107K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,623 | $107K |
| T2101 | Human breast milk processing, storage and distribution only | <1% | 4,528 | $102K |
| 73564 | <1% | 1,263 | $98K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,297 | $96K |
| 01992 | <1% | 2,767 | $90K | |
| 80053 | Comprehensive metabolic panel | <1% | 11,323 | $88K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,030 | $85K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,521 | $78K |
| 64494 | <1% | 751 | $76K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 85 | $76K |
| 73030 | <1% | 1,066 | $68K | |
| 27096 | <1% | 715 | $67K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 32,456 | $63K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,301 | $56K |
| 93321 | <1% | 657 | $55K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 939 | $54K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 802 | $50K |
| 76830 | Ultrasound, transvaginal | <1% | 897 | $49K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 148 | $42K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,047 | $41K |
| 76827 | <1% | 732 | $40K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 6,905 | $39K |
| 17110 | <1% | 417 | $34K | |
| 64635 | <1% | 48 | $32K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 470 | $31K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 910 | $27K |
| 72100 | <1% | 597 | $27K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,501 | $26K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,198 | $25K |
| 11102 | <1% | 225 | $25K | |
| 81025 | <1% | 5,095 | $25K | |
| 76000 | <1% | 1,336 | $25K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 91 | $23K |
| 90378 | <1% | 81 | $23K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 295 | $23K |
| 72110 | <1% | 343 | $22K | |
| 74178 | <1% | 55 | $21K | |
| 72082 | <1% | 375 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,043 | $18K |
| 80061 | Lipid panel | <1% | 1,871 | $18K |
| 94760 | <1% | 9,498 | $18K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 785 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,605 | $17K |
| 72040 | <1% | 343 | $16K | |
| 76642 | <1% | 220 | $16K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 387 | $15K |
| 0001A | <1% | 472 | $15K | |
| 64636 | <1% | 57 | $14K | |
| 86780 | <1% | 1,489 | $14K | |
| 0002A | <1% | 432 | $13K | |
| 11900 | <1% | 138 | $13K | |
| 86850 | <1% | 3,140 | $12K | |
| 11104 | <1% | 99 | $12K | |
| 80050 | General health panel | <1% | 376 | $11K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,558 | $11K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,294 | $10K |
| 64450 | <1% | 72 | $10K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 10,382 | $9K |
| 94761 | <1% | 2,983 | $9K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 8,959 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 670 | $8K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 300 | $7K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 536 | $7K |
| 80074 | <1% | 249 | $7K | |
| 90715 | <1% | 254 | $7K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 169 | $7K |
| 87210 | <1% | 2,323 | $7K | |
| 85027 | <1% | 1,383 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 335 | $6K |
| 71250 | <1% | 48 | $6K | |
| 70355 | <1% | 105 | $6K | |
| 86900 | <1% | 3,136 | $6K | |
| 76942 | <1% | 343 | $5K | |
| 86901 | <1% | 3,131 | $5K | |
| 86803 | <1% | 460 | $5K | |
| 0071A | <1% | 159 | $5K | |
| 82607 | <1% | 380 | $5K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 14 | $5K |
| 76818 | <1% | 62 | $5K | |
| 70250 | <1% | 61 | $5K | |
| 87081 | <1% | 893 | $5K | |
| 74018 | <1% | 62 | $4K | |
| 71045 | Radiologic examination, chest; single view | <1% | 64 | $4K |
| 72020 | <1% | 61 | $4K | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 2,096 | $4K |
| 86592 | <1% | 1,267 | $4K | |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | <1% | 19 | $4K |
| 95117 | <1% | 305 | $4K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 356 | $4K |
| 0072A | <1% | 106 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 66 | $3K |
| 85660 | <1% | 788 | $3K | |
| 86038 | <1% | 319 | $3K | |
| 86762 | <1% | 289 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 58 | $3K |
| 62321 | <1% | 15 | $3K | |
| 90678 | <1% | 40 | $3K | |
| 90651 | <1% | 13 | $3K | |
| 87340 | <1% | 383 | $3K | |
| 01940 | <1% | 19 | $3K | |
| 86140 | <1% | 587 | $2K | |
| 17000 | <1% | 57 | $2K | |
| 0004A | <1% | 70 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,000 | $2K |
| 0003A | <1% | 65 | $2K | |
| 83516 | <1% | 292 | $2K | |
| 90686 | <1% | 160 | $2K | |
| 93246 | <1% | 58 | $2K | |
| 94762 | <1% | 66 | $2K | |
| 86364 | <1% | 307 | $2K | |
| 73110 | <1% | 33 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 32 | $2K |
| 76810 | <1% | 14 | $2K | |
| 90656 | <1% | 317 | $2K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 409 | $2K |
| 82784 | <1% | 202 | $1K | |
| 88342 | <1% | 33 | $1K | |
| 20552 | <1% | 55 | $1K | |
| 84156 | <1% | 448 | $1K | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 1,017 | $1K |
| 77080 | <1% | 18 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 207 | $1K |
| 72120 | <1% | 26 | $1K | |
| 82977 | <1% | 250 | $1K | |
| 83615 | <1% | 246 | $1K | |
| 97161 | <1% | 16 | $1K | |
| 77062 | <1% | 14 | $930.12 | |
| 80177 | <1% | 101 | $861.25 | |
| 84439 | <1% | 161 | $847.88 | |
| 85651 | <1% | 253 | $814.50 | |
| 76641 | <1% | 12 | $800.49 | |
| 84550 | <1% | 238 | $787.64 | |
| 01400 | <1% | 14 | $761.70 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $681.24 |
| 72050 | <1% | 17 | $655.40 | |
| 82962 | <1% | 406 | $564.12 | |
| 86258 | <1% | 88 | $519.00 | |
| 82570 | <1% | 137 | $497.28 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,074 | $483.97 |
| 01160 | <1% | 19 | $472.18 | |
| 81000 | <1% | 132 | $470.73 | |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $398.85 |
| 81003 | <1% | 456 | $394.78 | |
| 85610 | <1% | 143 | $368.94 | |
| 86703 | <1% | 33 | $360.36 | |
| 64415 | <1% | 331 | $359.35 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,534 | $331.12 |
| 82728 | <1% | 31 | $302.59 | |
| 96112 | <1% | 212 | $299.88 | |
| 86706 | <1% | 43 | $279.24 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 775 | $268.52 |
| 83690 | <1% | 45 | $254.93 | |
| 88312 | <1% | 26 | $240.40 | |
| 83993 | <1% | 12 | $235.56 | |
| 82785 | <1% | 19 | $197.52 | |
| 80076 | <1% | 27 | $196.08 | |
| 86790 | <1% | 22 | $193.20 | |
| 0052A | <1% | 18 | $158.51 | |
| 86704 | <1% | 18 | $144.60 | |
| 85730 | <1% | 68 | $126.21 | |
| 87070 | <1% | 14 | $112.06 | |
| A9698 | Non-radioactive contrast imaging material, not otherwise classified, per study | <1% | 29 | $95.54 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 203 | $62.39 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 326 | $52.04 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | <1% | 58 | $47.39 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 804 | $33.82 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 597 | $31.62 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 950 | $27.15 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 19 | $27.04 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | <1% | 509 | $2.41 |
| 91300 | 0% | 1,006 | $0.00 | |
| C1729 | Catheter, drainage | 0% | 217 | $0.00 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 185 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 101 | $0.00 |
| 64447 | 0% | 73 | $0.00 | |
| 01830 | 0% | 35 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 30 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 113 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 195 | $0.00 |
| 91307 | 0% | 204 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGREEN, MITZI (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Lsu Health Sciences Center Shreveport Faculty Group Practice | Shreveport, LA | $235.66M |
| University Health Shreveport LLC | Shreveport, LA | $98.06M |
| BRFHH Monroe LLC | Monroe, LA | $56.71M |
| BRFHH Monroe LLC | Monroe, LA | $8.82M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.